Lobe Sciences Statistics
Total Valuation
Lobe Sciences has a market cap or net worth of CAD 4.58 million. The enterprise value is 6.44 million.
Market Cap | 4.58M |
Enterprise Value | 6.44M |
Important Dates
The last earnings date was Friday, January 24, 2025.
Earnings Date | Jan 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Lobe Sciences has 183.24 million shares outstanding. The number of shares has increased by 36.89% in one year.
Current Share Class | n/a |
Shares Outstanding | 183.24M |
Shares Change (YoY) | +36.89% |
Shares Change (QoQ) | +1.63% |
Owned by Insiders (%) | 1.42% |
Owned by Institutions (%) | n/a |
Float | 95.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.38 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.03 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.73 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -123.44% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 101.06% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +25.00% in the last 52 weeks. The beta is 2.00, so Lobe Sciences's price volatility has been higher than the market average.
Beta (5Y) | 2.00 |
52-Week Price Change | +25.00% |
50-Day Moving Average | 0.02 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 51.67 |
Average Volume (20 Days) | 10,701 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -15,398 |
Operating Income | -2.22M |
Pretax Income | -4.62M |
Net Income | -4.65M |
EBITDA | -2.14M |
EBIT | -2.22M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 45,550 in cash and 1.90 million in debt, giving a net cash position of -1.86 million or -0.01 per share.
Cash & Cash Equivalents | 45,550 |
Total Debt | 1.90M |
Net Cash | -1.86M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | -3.46M |
Book Value Per Share | -0.02 |
Working Capital | -2.20M |
Cash Flow
Operating Cash Flow | -610,573 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Lobe Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -36.89% |
Shareholder Yield | -36.89% |
Earnings Yield | -101.58% |
FCF Yield | n/a |
Stock Splits
The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.166666667.
Last Split Date | Jun 10, 2022 |
Split Type | Reverse |
Split Ratio | 0.166666667 |
Scores
Lobe Sciences has an Altman Z-Score of -1111.78. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1111.78 |
Piotroski F-Score | n/a |